Adverse impact of 1q amplification on outcomes in patients with multiple myeloma treated with daratumumab, carfilzomib and dexamethasone in a real-world clinical setting.
作者信息
Kikuchi Taku, Tsukada Nobuhiro, Kunisada Kodai, Matsumoto Chiaki, Nomura-Yogo Moe, Oda Yuki, Sato Kota, Takei Tomomi, Ogura Mizuki, Abe Yu, Suzuki Kenshi, Hosoya Osamu, Ishida Tadao
机构信息
Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
Department of Pharmacy, Japanese Red Cross Medical Center, Tokyo, Japan.
出版信息
Hematol Oncol. 2024 Sep;42(5):e3306. doi: 10.1002/hon.3306.
DOI:10.1002/hon.3306
PMID:39120040
Abstract
摘要
Zotero 插件